Updated 06:11 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,883.00 +0.78% CL 84.99 -0.85% BTC 64,683.65 -0.95%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,883 +0.78% BTC $64,684 −0.95% VIX 22.91 +18.70% latest tape · as of 06:11 UTC
The Screen · Financials · Banks - Regional

Bank Rakyat Indonesia

BBRI.JK · IDX · IDR · Market cap $447.21T · 82,203 employees

PT Bank Rakyat Indonesia (Persero) Tbk provides various banking products and services in Indonesia and internationally.

FAIL · Does not pass the screen
3,060.00 IDR

Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-11-13 · the tape above runs as of 06:11 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price3,060.00 IDR at the 13 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 13 Nov 2026
  • Our regime readDistribution, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed13 Nov 2026 (4 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: 4,812.50 IDR to 6,120.00 IDR, base estimate 4,812.50 IDR (screen dated 2026-11-13).

Current read
Distribution ?
Undervalued · screened 2026-11-13
  • Trend Distribution
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price3,060.00 IDR
Fair value4,812.50
Ethical score30.0/100
Value readUndervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-10-26Read Distribution3,300.00-7.3% to today ✓Accumulation gives way to Distribution after an 11% rise in 8 weeks
2026-08-28Read Accumulation2,970.00+3.0% to today ✓Distribution gives way to Accumulation with volume flow in agreement
2026-07-25Read Distribution2,970.00+3.0% to today Markup gives way to Distribution
2026-07-02Read Markup2,850.00+7.4% to today ✓First review on file: Markup

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

Bank Rakyat Indonesia holds its Distribution at $3,060.00. The statistical read favours the buyers, held for 19 days.

As held on the ledger · 2026-11-13
PhaseDistribution · caution
Quantitative stateThe statistical read favours the buyers, held for 19 days
Price at the screen$3,060.00
Valuation8.48 trailing · 7.50 forward price to earnings
Values screenFAIL · score 30.0
Beta0.22
The Workings

Five Screens, Shown in Full

Does not pass. Business activity screen

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Bank — FAIL on business activity Fail
Debt load 8.04% Below 33% Interest-bearing debt is just 8.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 5.92% Below 33% Cash held in interest-bearing accounts and securities is 5.9% of assets, under the one-third limit. Pass
Receivables 3.23% Below 49% Money owed to the company is 3.2% of assets, under the 49% limit. Pass
Revenue purity 73.23% Below 5% 73.2% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Bank Rakyat Indonesia does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when BBRI.JK's ethical verdict changes

Today BBRI.JK does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 13 Nov 2026: it trades at roughly a 36% discount to our 4,812.50 IDR fair value, 16.30% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

4,812.50Conservative4,812.50Base case6,120.00Growth case 3,060.00Price

Fair value range in IDR, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. A 36.4% discount to the base estimate.

The Street's Range
2,730.00Street low 3,850.00Street average 4,900.00Street high 3,060.00Price

Third-party analyst targets: 22 covering, consensus Buy. The average target sits +26% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate 4,812.50 IDR, with a range of 4,812.50 IDR to 6,120.00 IDR, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it stands out

A 16%-growth business trading at just 7.5x forward earnings. That is a 36% discount to our 4,812.50 IDR fair value: the market is pricing it cautiously while the fundamentals argue otherwise. 22 analysts rate it Buy with a 3,850.00 IDR average target, about 26% above the screened price.

The fundamentals · plain-English read
Forward P/E7.5xcheap for a company growing this fast
Trailing P/E8.5xvery cheap relative to earnings
EPS, trailing389.07
EPS, forward440.19
Revenue growth+16.3%steady growth
Profit margin40.2%highly profitable on every dollar of sales
Return on equity18.1%a solid return on shareholder capital
Dividend yield14.67%
Beta0.22barely tracks the market's swings
52-week range2,540.00 - 4,270.00
Market cap$447.21T
Employees82,203

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: its business and earnings are exposed to Indonesia and to currency swings.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

BBRI.JK trades on IDX (the company is based in Indonesia). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-06 Distribution $2,710.00 -17.9% Entry 15

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 17.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $4055.

2026-10-26 Distribution · changed $3,300.00 +0.0% Entry 14

The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $4055.

2026-10-13 Accumulation $3,300.00 +0.0% Entry 13

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $4055.

2026-10-02 Accumulation $3,300.00 +11.1% Entry 12

Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 11.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $4055.

2026-08-28 Accumulation · changed $2,970.00 +0.0% Entry 11

The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $4055.

2026-07-28 Distribution $2,970.00 +0.0% Entry 10

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $4055. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-27 Distribution $2,970.00 +0.0% Entry 9

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $4055. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-26 Distribution $2,970.00 +0.0% Entry 8

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $4055. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-25 Distribution · changed $2,970.00 +0.0% Entry 7

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $4055. It reported earnings in this window, a natural checkpoint for the thesis.

2026-07-24 Markup $2,970.00 +0.0% Entry 6

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 23%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (21 analysts) rates it buy, with a mean price target of $4055. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $3,200.00 -10.0% · $900 -10.0%
2 months $3,184.04 -9.6% $209.00 $970 -3.0%
3 months $3,353.10 -14.1% $209.00 $921 -7.9%
6 months $3,285.89 -12.4% $346.00 $982 -1.8%
1 year $3,756.59 -23.3% $346.00 $859 -14.1%
2 years $3,643.46 -21.0% $689.40 $980 -2.0%
3 years $4,263.78 -32.5% $1,008.40 $912 -8.8%
5 years $2,767.81 +4.1% $1,470.87 $1,572 +57.2%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever BBRI.JK does next, these words stay.

Bank Rakyat Indonesia · BBRI.JK · Distribution · $3,060.00
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.